110 related articles for article (PubMed ID: 37023366)
1. iMSEA: A Novel Metabolite Set Enrichment Analysis Strategy to Decipher Drug Interactions.
Wang Y; Liu X; Dong L; Cheng KK; Lin C; Wang X; Dong J; Deng L; Raftery D
Anal Chem; 2023 Apr; 95(15):6203-6211. PubMed ID: 37023366
[TBL] [Abstract][Full Text] [Related]
2.
Lin C; Dong J; Wei Z; Cheng KK; Li J; You S; Liu Y; Wang X; Chen Z
J Proteome Res; 2020 Feb; 19(2):781-793. PubMed ID: 31916767
[TBL] [Abstract][Full Text] [Related]
3. The aspartate metabolism pathway is differentiable in human hepatocellular carcinoma: transcriptomics and (13) C-isotope based metabolomics.
Darpolor MM; Basu SS; Worth A; Nelson DS; Clarke-Katzenberg RH; Glickson JD; Kaplan DE; Blair IA
NMR Biomed; 2014 Apr; 27(4):381-9. PubMed ID: 24497316
[TBL] [Abstract][Full Text] [Related]
4. Differential Correlations Informed Metabolite Set Enrichment Analysis to Decipher Metabolic Heterogeneity of Disease.
Lin G; Dong L; Cheng KK; Xu X; Wang Y; Deng L; Raftery D; Dong J
Anal Chem; 2023 Aug; 95(33):12505-12513. PubMed ID: 37557184
[TBL] [Abstract][Full Text] [Related]
5. Sparse PLS-Based Method for Overlapping Metabolite Set Enrichment Analysis.
Deng L; Ma L; Cheng KK; Xu X; Raftery D; Dong J
J Proteome Res; 2021 Jun; 20(6):3204-3213. PubMed ID: 34002606
[TBL] [Abstract][Full Text] [Related]
6. Aberrant Metabolism in Hepatocellular Carcinoma Provides Diagnostic and Therapeutic Opportunities.
De Matteis S; Ragusa A; Marisi G; De Domenico S; Casadei Gardini A; Bonafè M; Giudetti AM
Oxid Med Cell Longev; 2018; 2018():7512159. PubMed ID: 30524660
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatic and experimental data decipher the pharmacological targets and mechanisms of plumbagin against hepatocellular carcinoma.
Zhou R; Wu K; Su M; Li R
Environ Toxicol Pharmacol; 2019 Aug; 70():103200. PubMed ID: 31158732
[TBL] [Abstract][Full Text] [Related]
8. The potential mechanism of Chebulae Fructus in the treatment of hepatocellular carcinoma on the basis of network pharmacology.
Jiang J; Yang Z; Hou G; Yao X; Jiang J
Ann Hepatol; 2022; 27(4):100701. PubMed ID: 35351639
[TBL] [Abstract][Full Text] [Related]
9. Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis.
Mou T; Zhu D; Wei X; Li T; Zheng D; Pu J; Guo Z; Wu Z
World J Surg Oncol; 2017 Mar; 15(1):63. PubMed ID: 28302149
[TBL] [Abstract][Full Text] [Related]
10. Identification of Key Functional Modules and Immunomodulatory Regulators of Hepatocellular Carcinoma.
Luo D; Zhang X; Li XK; Chen G
J Immunol Res; 2021; 2021():1801873. PubMed ID: 34423049
[TBL] [Abstract][Full Text] [Related]
11. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Metabolomic Analysis Reveals Dynamic Metabolic Reprogramming in Hep3B Cells with Aflatoxin B1 Exposure.
Wang S; Yang X; Liu F; Wang X; Zhang X; He K; Wang H
Toxins (Basel); 2021 May; 13(6):. PubMed ID: 34072178
[TBL] [Abstract][Full Text] [Related]
13. Systems Pharmacology-Based Identification of Mechanisms of Action of Bolbostemma paniculatum for the Treatment of Hepatocellular Carcinoma.
Wang LL; Liao C; Li XQ; Dai R; Ren QW; Shi HL; Wang XP; Feng XS; Chao X
Med Sci Monit; 2021 Jan; 27():e927624. PubMed ID: 33436534
[TBL] [Abstract][Full Text] [Related]
14. Comparative Metabolomic Profiling of Hepatocellular Carcinoma Cells Treated with Sorafenib Monotherapy vs. Sorafenib-Everolimus Combination Therapy.
Zheng JF; Lu J; Wang XZ; Guo WH; Zhang JX
Med Sci Monit; 2015 Jun; 21():1781-91. PubMed ID: 26092946
[TBL] [Abstract][Full Text] [Related]
15. Systems Network Pharmacology-Based Prediction and Analysis of Potential Targets and Pharmacological Mechanism of
Hu Y; Yang L; Lu Y; Wang Y; Jiang J; Liu Y; Cao Q
Evid Based Complement Alternat Med; 2022; 2022():2116006. PubMed ID: 36193154
[TBL] [Abstract][Full Text] [Related]
16. Integrated spatially resolved metabolomics and network toxicology to investigate the hepatotoxicity mechanisms of component D of Polygonum multiflorum Thunb.
Jiang HY; Gao HY; Li J; Zhou TY; Wang ST; Yang JB; Hao RR; Pang F; Wei F; Liu ZG; Kuang L; Ma SC; He JM; Jin HT
J Ethnopharmacol; 2022 Nov; 298():115630. PubMed ID: 35987407
[TBL] [Abstract][Full Text] [Related]
17. [Urine metabolomics study of hepatocellular carcinoma].
Xie XF; Sun Y; Zhao XH
Zhonghua Zhong Liu Za Zhi; 2022 Mar; 44(3):252-259. PubMed ID: 35316875
[No Abstract] [Full Text] [Related]
18. Cell metabolomics study on synergistic anti-hepatocellular carcinoma effect of Aidi injection combined with doxorubicin.
Wang Y; Zhu X; Wang K; Cai Y; Liu C; Pan J; Sun J; Liu T; Huang Y; Li Y; Lu Y
Biomed Chromatogr; 2022 Oct; 36(10):e5451. PubMed ID: 35848595
[TBL] [Abstract][Full Text] [Related]
19. Bioinformatics analysis of key genes and pathways for hepatocellular carcinoma transformed from cirrhosis.
He B; Yin J; Gong S; Gu J; Xiao J; Shi W; Ding W; He Y
Medicine (Baltimore); 2017 Jun; 96(25):e6938. PubMed ID: 28640074
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]